Answers are grounded in this paper and cite their sources.
This review encompasses comprehensive literature on synthetic modification and biological activities of clinically used neomycin-class aminoglycoside antibiotics to alleviate dose-related toxicity and pathogenic resistance.
No takes yet. Share an insight, caveat, or question.
Bera et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: